Slide 1Luso del placebo in studi su patologie con dolore Pierangelo Geppetti Farmacologia Clinica, Università di Firenze Centro Cefalee, AOU S. Anna, Ferrara Slide 2 Placebo…

Slide 1ICTW Punta del Este, Uruguay Max S. Mano Assist. Prof. Medical Oncology – University of São Paulo (USP/ICESP) Medical Oncology – Hospital Sírio Libanês Regulatory…

Slide 1Research-Based Consumer Advocacy: Data Analyses Facilitate Early Warnings to Patients, Withdrawals of Dangerous Drugs Sidney M. Wolfe MD Public Citizens Health Research…

Slide 1Change Can Happen: New Trends in Clinical Trials in the U.S. Peter Lurie, MD, MPH Health Research Group at Public Citizen Presented at HAI Europe Open Seminar Neues…

1. What makes clinical trials in orphan indications so special? 3 MARCH 2014© 2014 SynteractHCR. All rights reserved.SHARED WORK. SHARED VISION. 2. 2Milestone Legislations…

Research Methodology By Dr Alok Misra Post Graduate Trainee Dept. of Organon of Medicine Under Guidance Of Prof L M Khan HOD, Organon of Medicine, National Institute of Homoeopathy…

Slide 1 From Clinical Trials to Treatments: 0 → → 9 and Counting… Slide 2 Outline for today The clinical trial process How clinical trials are changing Progress to…

Legal aspects of clinical trials (patients, investigators, sponsor) and Reporting requirements of local regulatory bodies Max S. Mano Assist. Prof. Medical Oncology â University…

January 9, 2013 Ethical Considerations in Substance Abuse and Addiction Research Sandra L. Alfano, Pharm.D. Chair, HIC II and IV Research Scientist, General Internal Medicine…

Post-trial Access to Treatment by Patients participating in Clinical Trials Presented by Dr T K S Letlape Chairman: South African Medical Association President-Elect: World…